Legal marijuana is poised to become the next Big Tobacco, and has serious implications for employers' bottom line, employee health, and workplace safety
The document summarizes the findings of a poll conducted by SHRM and DATIA on drug testing efficacy. Some key findings include:
- Over half of organizations conduct pre-employment drug testing on all job candidates, while 29% do not have a testing program.
- Organizations that implemented drug testing programs reported decreases in absenteeism (50%), workers' compensation rates (50%), and employee turnover (16%). Productivity increased in 19% of organizations.
- Larger organizations and publicly-owned for-profits were more likely to conduct pre-employment testing on all candidates compared to smaller organizations and other sectors.
This survey by the Society for Human Resource Management examined policies related to marijuana use in the workplace in states that have legalized medical and/or recreational marijuana use. The key findings were:
1) The vast majority (94%) of organizations surveyed had a formal substance use policy, with policies specifically addressing marijuana use more common where it was legalized for both medical and recreational use.
2) Most organizations (73-82%) had a zero-tolerance policy prohibiting marijuana use while working.
3) Common disciplinary actions for first violations included termination (41-50%), mandatory drug counseling (16-21%), and written warnings (14-19%).
4) Around half of organizations conducted pre-employment
Over half of organizations allow smoking in the workplace. Most have formal smoking policies, and many limit the number of daily breaks. Common smoking policies provide wellness information on quitting or impose health premium surcharges for smokers. Since implementing these policies, many report decreased smoking. Vaping policies are also increasing, with most either banning or designating vaping areas. Violations typically result in verbal warnings.
The survey found that:
- Two-thirds of organizations offered wellness programs, and 40% increased investment in these programs.
- Most organizations did not analyze return on investment or cost savings from wellness programs.
- Around half of organizations saw increased employee participation in wellness programs over time.
- Wellness programs were viewed as effective in reducing healthcare costs and improving employee health.
- About 60% of organizations offered wellness incentives like premium reductions, which significantly increased employee participation.
SHRM Survey Findings: Smoking in the Workplaceshrm
Over half of organizations allow smoking in the workplace. Most have formal smoking policies, and many limit the number of daily breaks. Common smoking policies provide wellness information on quitting or impose health premium surcharges for smokers. Since implementing these policies, many report decreased smoking. Vaping policies are also increasing, with most either banning or designating vaping areas. Violations typically result in verbal warnings.
SHRM’s 2014 Strategic Benefits Survey: Health Careshrm
SHRM’s 2014 Strategic Benefits Survey collected extensive information on the costs of health care and changes in total costs over time.
This research found that about four-fifths (79%) of respondents from organizations that provided health care coverage to their employees indicated their organization was “very concerned” about controlling health care costs. About one-half of organizations offered educational initiatives related to health and wellness (56%) and/or lower-cost generic prescription drugs (48%) to help control the costs of health care. In terms of employee contributions to the total costs of health care, one-half of respondents indicated their organization increased the employee share of the total costs of health care compared with the previous plan year.
The majority of organizations do not have formal policies against hiring smokers. The most common smoking policy designates specific outdoor smoking areas, though this has decreased in recent years. Smoking policies are typically communicated through employee handbooks, orientations, and signs. Most organizations take disciplinary action like warnings for smoking policy violations. Around 20% offer health insurance discounts for non-smokers or those in cessation programs.
This document summarizes findings from a SHRM survey on employee health care benefits in California. Key findings include:
- Many organizations are unsure if employees will pay more for health care costs in the future, though around 1/5 expect employees to cover the majority of costs within 3-5 years.
- Common strategies to control costs include increasing employee premium contributions and promoting health/wellness.
- Respondents were split on whether their organizations planned to increase employee premium contributions for the next plan year.
- Most organizations currently pay the majority of total health care costs, though some expect this to change to employees paying more.
The document summarizes the findings of a poll conducted by SHRM and DATIA on drug testing efficacy. Some key findings include:
- Over half of organizations conduct pre-employment drug testing on all job candidates, while 29% do not have a testing program.
- Organizations that implemented drug testing programs reported decreases in absenteeism (50%), workers' compensation rates (50%), and employee turnover (16%). Productivity increased in 19% of organizations.
- Larger organizations and publicly-owned for-profits were more likely to conduct pre-employment testing on all candidates compared to smaller organizations and other sectors.
This survey by the Society for Human Resource Management examined policies related to marijuana use in the workplace in states that have legalized medical and/or recreational marijuana use. The key findings were:
1) The vast majority (94%) of organizations surveyed had a formal substance use policy, with policies specifically addressing marijuana use more common where it was legalized for both medical and recreational use.
2) Most organizations (73-82%) had a zero-tolerance policy prohibiting marijuana use while working.
3) Common disciplinary actions for first violations included termination (41-50%), mandatory drug counseling (16-21%), and written warnings (14-19%).
4) Around half of organizations conducted pre-employment
Over half of organizations allow smoking in the workplace. Most have formal smoking policies, and many limit the number of daily breaks. Common smoking policies provide wellness information on quitting or impose health premium surcharges for smokers. Since implementing these policies, many report decreased smoking. Vaping policies are also increasing, with most either banning or designating vaping areas. Violations typically result in verbal warnings.
The survey found that:
- Two-thirds of organizations offered wellness programs, and 40% increased investment in these programs.
- Most organizations did not analyze return on investment or cost savings from wellness programs.
- Around half of organizations saw increased employee participation in wellness programs over time.
- Wellness programs were viewed as effective in reducing healthcare costs and improving employee health.
- About 60% of organizations offered wellness incentives like premium reductions, which significantly increased employee participation.
SHRM Survey Findings: Smoking in the Workplaceshrm
Over half of organizations allow smoking in the workplace. Most have formal smoking policies, and many limit the number of daily breaks. Common smoking policies provide wellness information on quitting or impose health premium surcharges for smokers. Since implementing these policies, many report decreased smoking. Vaping policies are also increasing, with most either banning or designating vaping areas. Violations typically result in verbal warnings.
SHRM’s 2014 Strategic Benefits Survey: Health Careshrm
SHRM’s 2014 Strategic Benefits Survey collected extensive information on the costs of health care and changes in total costs over time.
This research found that about four-fifths (79%) of respondents from organizations that provided health care coverage to their employees indicated their organization was “very concerned” about controlling health care costs. About one-half of organizations offered educational initiatives related to health and wellness (56%) and/or lower-cost generic prescription drugs (48%) to help control the costs of health care. In terms of employee contributions to the total costs of health care, one-half of respondents indicated their organization increased the employee share of the total costs of health care compared with the previous plan year.
The majority of organizations do not have formal policies against hiring smokers. The most common smoking policy designates specific outdoor smoking areas, though this has decreased in recent years. Smoking policies are typically communicated through employee handbooks, orientations, and signs. Most organizations take disciplinary action like warnings for smoking policy violations. Around 20% offer health insurance discounts for non-smokers or those in cessation programs.
This document summarizes findings from a SHRM survey on employee health care benefits in California. Key findings include:
- Many organizations are unsure if employees will pay more for health care costs in the future, though around 1/5 expect employees to cover the majority of costs within 3-5 years.
- Common strategies to control costs include increasing employee premium contributions and promoting health/wellness.
- Respondents were split on whether their organizations planned to increase employee premium contributions for the next plan year.
- Most organizations currently pay the majority of total health care costs, though some expect this to change to employees paying more.
This document summarizes key findings from a survey on employee health care benefits in California. It finds that many organizations are unsure if employees will pay more for health care costs in the future. Organizations are using strategies like increasing employee premium contributions and promoting wellness to control costs. Larger organizations and public companies were more likely to increase employee contributions in 2013. Common cost-control activities included wellness programs, generic drugs, and consumer-directed health plans.
The 2013 Healthcare Benefits Trends Benchmark Study report provides insights into the adoption of new healthcare benefits, health exchanges, wellness, and related topics. The survey polled more than 300 human resources (HR) executives, benefit specialists, and other benefit decision-makers across the country to explore the current state of employee healthcare benefits, as well as the expected healthcare benefits outlook in response to sweeping healthcare reform legislation, also known as the Affordable Care Act (ACA). This includes the shift to defined contribution health plans, the launch of insurance exchanges, and the implementation of wellness plans.
This document summarizes a presentation on the financial toll of prescription drug addiction from the perspective of third-party payers. It includes presentations from experts at the CDC, a private insurance company, and a university. The presentations outline national trends in opioid use and expenditures, strategies used by an insurance company to identify and manage high-risk opioid claims, and a description of North Carolina's Medicaid Lock-In Program aimed at curbing prescription drug misuse. The document provides disclosure statements for each presenter and learning objectives for the session.
Shrm us travel-vacation-benefits-workplace-impactshrm
HR professionals believe that taking vacation is important for employees. Most think it is extremely or very important for performance (94%), morale (92%), wellness (92%), culture (90%), and productivity (90%). Organizations commonly provide 11-15 paid vacation days annually but many employees do not use all their days. HR professionals agree employees who take more vacation have higher job satisfaction, performance, and productivity than those taking less time off.
Senior management in larger organizations and those with self-insured health plans were more likely to ask HR to provide an overview of health care reform implications. HR addressed short-term issues like knowledge of the new law and immediate financial impacts before long-term strategic issues. HR also focused on compliance requirements and financial implications with leadership of larger, self-insured, and multinational organizations. The poll surveyed over 1,000 HR professionals and had a 21% response rate.
- The 2014 SHRM survey found that 20% of organizations saw decreases in total healthcare costs compared to previous years where only 9-10% saw decreases. However, 69-74% still saw costs increase.
- Most organizations (79%) are very concerned about controlling healthcare costs. Common strategies include wellness initiatives (56%), generic drugs (48%), and increasing employee contributions (50%).
- Looking ahead, more employers may ask employees to take on more of the costs, but this could impact employee satisfaction and recruiting if not managed carefully. Wellness programs are also likely to remain a key strategy to control costs.
This document summarizes a panel discussion on lessons learned from prescription drug supply-side interventions. The panel included experts from Brown University, a policy advocacy group, and a law firm. They discussed research evaluating the impact of Florida's crackdown on "pill mills" that distributed oxycodone. Preliminary findings suggest supply-side interventions reduced drug availability and increased prices, with no evidence of recovery in supply. There was also no increase in other drugs, and interventions may have reduced abuse and improved public health. The panel then outlined strategies to protect consumers from black market prescription drugs, such as educating prescribers, reducing available supply of drugs for abuse, and developing abuse-deterrent formulations.
The NHS Confederation survey of 252 healthcare leaders found that the financial position of the NHS is very serious and getting worse. Three-quarters said pressures were the worst ever and 85% expect further pressure over the next year. Most said patient care had been affected, particularly experience, and this is expected to spread. Radical long-term changes are needed like integrating care and expanding community services, but short-term the NHS is cutting costs. The NHS chief executive warns that without action the NHS faces serious risks and the public needs to support necessary changes to services to ensure sustainability.
This document summarizes a presentation on data-driven trends related to prescription drug abuse. It outlines national trends in doctor shopping, overdoses, drugged driving, and opioid/heroin overdose deaths. It also evaluates the effectiveness of some state laws and programs aimed at reducing doctor shopping and responding to overdoses. Some promising policy strategies discussed include reducing inappropriate prescribing, focusing on overdose response, improving prescription drug monitoring programs, and linking overdose victims to treatment.
This document summarizes a presentation on legislative and medication trends impacting third-party payers. It discusses several topics: physician dispensing and repackaged medications, opioid utilization, treatment guidelines and closed formularies, and compounded medications. For each topic, it outlines related legislative strategies and regulatory approaches taken by different states to influence costs and utilization for third-party payers. The presentation aims to identify issues relevant to third-party payers and explain how they can shape legislative and regulatory outcomes.
The document summarizes findings from a SHRM survey on employee health care benefits. Key findings include: Most organizations are very concerned about controlling health care costs and have engaged in health/wellness educational initiatives and culture changes to do so. Looking ahead, many organizations are unsure if employees will pay more for health care costs in the future, though some large organizations currently increase employee contributions. HR professionals will need to balance health care costs with attracting and retaining employees under reforms like the Affordable Care Act.
1. A RAND study found that workplace wellness programs are only cost-effective when they focus on helping employees manage chronic health conditions, rather than general health habits among healthy employees.
2. Many employers are rethinking their approaches to wellness programs due to doubts about their effectiveness in improving health and reducing costs. Some companies are focusing more on environmental changes and better engaging employees.
3. Financial incentives are common in wellness programs but have been controversial, as they could unfairly shift costs to employees in poorer health. Regulations now limit the size of incentives.
This presentation given by WIMHRT West at the January 4, 2008, TWG meeting covers results from a
survey of Washington State providers on their use of Evidence Based Practics.
This document summarizes a webinar on prescription drug costs and purchasing strategies for employers. It includes:
1) An agenda for the webinar outlining presentations on current employer strategies, additional strategies employers can implement, and purchasing and policy options.
2) A discussion of employer survey results finding specialty drugs are a top cost concern and priorities include better vendor management and transparency.
3) Presentations from groups in Minnesota and Ohio on their initiatives. These include employer learning networks, analyzing vendor relationships and costs across pharmacy and medical benefits, and developing action plans including standardizing data and reimbursement.
4) The document advocates employers evaluate all strategies like traditional utilization management, pursue innovative approaches with vendors,
The document provides a summary of key findings from the 2014 UBA Health Plan Survey. Some notable trends include employers increasingly using early renewal strategies to delay cost increases from the Affordable Care Act. Average premium increases were 5.6% but some small employers saw increases over 30%. Employers are also shifting more costs to employees through higher deductibles and out-of-pocket maximums. While self-funding among small employers only increased slightly, this approach may grow in popularity as a way to avoid some ACA requirements. Overall the survey finds employers continuing to manage health care costs through plan changes and cost-shifting despite ongoing uncertainty around the impacts of health reform.
This document provides an overview and update on the ADA and GINA regulations regarding workplace wellness programs. It discusses key cases like EEOC v. Flambeau that impacted the ADA rules. The final rules from the EEOC place a 30% incentive limit for wellness programs and require protections for collected medical information. GINA allows incentives for a spouse's health information with authorization but prohibits family history inquiries. Employers must comply with both laws which aim to protect employee privacy and prevent discrimination.
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders.
Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information.
This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies.
Download Full Report: http://bit.ly/2e3sl9Q
The document is a survey of over 4,000 employers about their reactions and responses to the Affordable Care Act. It finds that over 3/4 of respondents say healthcare reform has increased their benefit costs, and over half plan to pass these costs onto employees. It also discusses employers' views on issues like the individual mandate, health insurance exchanges, workplace wellness programs, and overall compliance with the law.
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesAtlantic Training, LLC.
This document provides an overview of a supervisor drug awareness and reasonable suspicion training class. The objectives of the training are to educate supervisors on regulations regarding drug and alcohol testing, their roles and responsibilities, the costs of substance abuse, types of testing procedures, and how to determine reasonable suspicion. The training aims to teach supervisors how to identify and address issues related to drugs and alcohol in the workplace. It also covers how substance abuse affects businesses through increased costs. The training outlines federal DOT regulations for testing commercial drivers and testing procedures outlined in company policies. It provides facts on drug addiction and commonly abused substances, and gives examples of applying testing and policy rules in real workplace situations.
Stuart presented on medical marijuana in the workplace at a LegalEase Breakfast Seminar hosted by the Human Resources Professional Association (HRPA) on February 25, 2016.
Legalization of Marijuana Webinar- Impact for Drug Testing Employers Eliassen Group
This document discusses the impact of legalizing marijuana and drug testing in the workplace. It notes that 23 states have legalized medical marijuana, creating challenges for employers maintaining drug-free workplaces. Ohio ballot issue 3 proposes legalizing medical and recreational marijuana use for those over 21. The document outlines employers' responsibilities regarding drug policies, noting they are not required to accommodate marijuana use given its federal illegality. It provides best practices for employers, such as maintaining consistent drug policies prohibiting impairment from any illegal substances.
This document summarizes key findings from a survey on employee health care benefits in California. It finds that many organizations are unsure if employees will pay more for health care costs in the future. Organizations are using strategies like increasing employee premium contributions and promoting wellness to control costs. Larger organizations and public companies were more likely to increase employee contributions in 2013. Common cost-control activities included wellness programs, generic drugs, and consumer-directed health plans.
The 2013 Healthcare Benefits Trends Benchmark Study report provides insights into the adoption of new healthcare benefits, health exchanges, wellness, and related topics. The survey polled more than 300 human resources (HR) executives, benefit specialists, and other benefit decision-makers across the country to explore the current state of employee healthcare benefits, as well as the expected healthcare benefits outlook in response to sweeping healthcare reform legislation, also known as the Affordable Care Act (ACA). This includes the shift to defined contribution health plans, the launch of insurance exchanges, and the implementation of wellness plans.
This document summarizes a presentation on the financial toll of prescription drug addiction from the perspective of third-party payers. It includes presentations from experts at the CDC, a private insurance company, and a university. The presentations outline national trends in opioid use and expenditures, strategies used by an insurance company to identify and manage high-risk opioid claims, and a description of North Carolina's Medicaid Lock-In Program aimed at curbing prescription drug misuse. The document provides disclosure statements for each presenter and learning objectives for the session.
Shrm us travel-vacation-benefits-workplace-impactshrm
HR professionals believe that taking vacation is important for employees. Most think it is extremely or very important for performance (94%), morale (92%), wellness (92%), culture (90%), and productivity (90%). Organizations commonly provide 11-15 paid vacation days annually but many employees do not use all their days. HR professionals agree employees who take more vacation have higher job satisfaction, performance, and productivity than those taking less time off.
Senior management in larger organizations and those with self-insured health plans were more likely to ask HR to provide an overview of health care reform implications. HR addressed short-term issues like knowledge of the new law and immediate financial impacts before long-term strategic issues. HR also focused on compliance requirements and financial implications with leadership of larger, self-insured, and multinational organizations. The poll surveyed over 1,000 HR professionals and had a 21% response rate.
- The 2014 SHRM survey found that 20% of organizations saw decreases in total healthcare costs compared to previous years where only 9-10% saw decreases. However, 69-74% still saw costs increase.
- Most organizations (79%) are very concerned about controlling healthcare costs. Common strategies include wellness initiatives (56%), generic drugs (48%), and increasing employee contributions (50%).
- Looking ahead, more employers may ask employees to take on more of the costs, but this could impact employee satisfaction and recruiting if not managed carefully. Wellness programs are also likely to remain a key strategy to control costs.
This document summarizes a panel discussion on lessons learned from prescription drug supply-side interventions. The panel included experts from Brown University, a policy advocacy group, and a law firm. They discussed research evaluating the impact of Florida's crackdown on "pill mills" that distributed oxycodone. Preliminary findings suggest supply-side interventions reduced drug availability and increased prices, with no evidence of recovery in supply. There was also no increase in other drugs, and interventions may have reduced abuse and improved public health. The panel then outlined strategies to protect consumers from black market prescription drugs, such as educating prescribers, reducing available supply of drugs for abuse, and developing abuse-deterrent formulations.
The NHS Confederation survey of 252 healthcare leaders found that the financial position of the NHS is very serious and getting worse. Three-quarters said pressures were the worst ever and 85% expect further pressure over the next year. Most said patient care had been affected, particularly experience, and this is expected to spread. Radical long-term changes are needed like integrating care and expanding community services, but short-term the NHS is cutting costs. The NHS chief executive warns that without action the NHS faces serious risks and the public needs to support necessary changes to services to ensure sustainability.
This document summarizes a presentation on data-driven trends related to prescription drug abuse. It outlines national trends in doctor shopping, overdoses, drugged driving, and opioid/heroin overdose deaths. It also evaluates the effectiveness of some state laws and programs aimed at reducing doctor shopping and responding to overdoses. Some promising policy strategies discussed include reducing inappropriate prescribing, focusing on overdose response, improving prescription drug monitoring programs, and linking overdose victims to treatment.
This document summarizes a presentation on legislative and medication trends impacting third-party payers. It discusses several topics: physician dispensing and repackaged medications, opioid utilization, treatment guidelines and closed formularies, and compounded medications. For each topic, it outlines related legislative strategies and regulatory approaches taken by different states to influence costs and utilization for third-party payers. The presentation aims to identify issues relevant to third-party payers and explain how they can shape legislative and regulatory outcomes.
The document summarizes findings from a SHRM survey on employee health care benefits. Key findings include: Most organizations are very concerned about controlling health care costs and have engaged in health/wellness educational initiatives and culture changes to do so. Looking ahead, many organizations are unsure if employees will pay more for health care costs in the future, though some large organizations currently increase employee contributions. HR professionals will need to balance health care costs with attracting and retaining employees under reforms like the Affordable Care Act.
1. A RAND study found that workplace wellness programs are only cost-effective when they focus on helping employees manage chronic health conditions, rather than general health habits among healthy employees.
2. Many employers are rethinking their approaches to wellness programs due to doubts about their effectiveness in improving health and reducing costs. Some companies are focusing more on environmental changes and better engaging employees.
3. Financial incentives are common in wellness programs but have been controversial, as they could unfairly shift costs to employees in poorer health. Regulations now limit the size of incentives.
This presentation given by WIMHRT West at the January 4, 2008, TWG meeting covers results from a
survey of Washington State providers on their use of Evidence Based Practics.
This document summarizes a webinar on prescription drug costs and purchasing strategies for employers. It includes:
1) An agenda for the webinar outlining presentations on current employer strategies, additional strategies employers can implement, and purchasing and policy options.
2) A discussion of employer survey results finding specialty drugs are a top cost concern and priorities include better vendor management and transparency.
3) Presentations from groups in Minnesota and Ohio on their initiatives. These include employer learning networks, analyzing vendor relationships and costs across pharmacy and medical benefits, and developing action plans including standardizing data and reimbursement.
4) The document advocates employers evaluate all strategies like traditional utilization management, pursue innovative approaches with vendors,
The document provides a summary of key findings from the 2014 UBA Health Plan Survey. Some notable trends include employers increasingly using early renewal strategies to delay cost increases from the Affordable Care Act. Average premium increases were 5.6% but some small employers saw increases over 30%. Employers are also shifting more costs to employees through higher deductibles and out-of-pocket maximums. While self-funding among small employers only increased slightly, this approach may grow in popularity as a way to avoid some ACA requirements. Overall the survey finds employers continuing to manage health care costs through plan changes and cost-shifting despite ongoing uncertainty around the impacts of health reform.
This document provides an overview and update on the ADA and GINA regulations regarding workplace wellness programs. It discusses key cases like EEOC v. Flambeau that impacted the ADA rules. The final rules from the EEOC place a 30% incentive limit for wellness programs and require protections for collected medical information. GINA allows incentives for a spouse's health information with authorization but prohibits family history inquiries. Employers must comply with both laws which aim to protect employee privacy and prevent discrimination.
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Best Practices
The Medical Affairs function plays an important role in health outcomes (HO) information exchange between bio-pharmaceutical organizations and key external stakeholders.
Development of robust health outcomes capabilities within Medical Affairs function requires an increase in the function’s involvement with health outcomes groups, development of field-based health outcomes capabilities, customization of health outcomes data as per stakeholders’ needs, and building real world data capabilities to generate and utilize health outcomes information.
This benchmarking research from Best Practices, LLC is designed to assist companies focused on oncology therapies find better ways to develop effective health outcomes groups. It provides current data and best practices from Medical Affairs leaders with an oncology focus at leading bio-pharmaceutical companies.
Download Full Report: http://bit.ly/2e3sl9Q
The document is a survey of over 4,000 employers about their reactions and responses to the Affordable Care Act. It finds that over 3/4 of respondents say healthcare reform has increased their benefit costs, and over half plan to pass these costs onto employees. It also discusses employers' views on issues like the individual mandate, health insurance exchanges, workplace wellness programs, and overall compliance with the law.
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesAtlantic Training, LLC.
This document provides an overview of a supervisor drug awareness and reasonable suspicion training class. The objectives of the training are to educate supervisors on regulations regarding drug and alcohol testing, their roles and responsibilities, the costs of substance abuse, types of testing procedures, and how to determine reasonable suspicion. The training aims to teach supervisors how to identify and address issues related to drugs and alcohol in the workplace. It also covers how substance abuse affects businesses through increased costs. The training outlines federal DOT regulations for testing commercial drivers and testing procedures outlined in company policies. It provides facts on drug addiction and commonly abused substances, and gives examples of applying testing and policy rules in real workplace situations.
Stuart presented on medical marijuana in the workplace at a LegalEase Breakfast Seminar hosted by the Human Resources Professional Association (HRPA) on February 25, 2016.
Legalization of Marijuana Webinar- Impact for Drug Testing Employers Eliassen Group
This document discusses the impact of legalizing marijuana and drug testing in the workplace. It notes that 23 states have legalized medical marijuana, creating challenges for employers maintaining drug-free workplaces. Ohio ballot issue 3 proposes legalizing medical and recreational marijuana use for those over 21. The document outlines employers' responsibilities regarding drug policies, noting they are not required to accommodate marijuana use given its federal illegality. It provides best practices for employers, such as maintaining consistent drug policies prohibiting impairment from any illegal substances.
Our goal is to provide an environment where patients are treated with the compassion and understanding they deserve. We want to make the process informative yet simple.
The student filmmakers will create a documentary investigating whether marijuana should be legalized for medical purposes. They will interview individuals including a chronic back pain sufferer, the president of an organization supporting cannabis law reform, a drug dealer, and a scientist. The documentary aims to present different perspectives on the medical efficacy and legalization of marijuana.
Stuart Rudner spoke at the Benefits3 Conference 2016 where he addressed medical marijuana; finding the balance between the duty to accommodate and the need to keep the workplace safe.
Conference Board of Canada Presentation: Medical marijuana in the workplaceRudner Law
This document summarizes key points from a presentation on accommodating medical marijuana in the workplace. It discusses the duty to accommodate under human rights law, including establishing discrimination, bona fide occupational requirements, and undue hardship. It reviews case law related to medical marijuana and outlines best practices for employers, such as having clear policies and processes for responding to accommodation requests and managing suspected abuse. Employers are advised to avoid stereotyping, consider human rights issues, and document all aspects of assessing and determining accommodations.
This document discusses hand safety and common hand injuries. It states that over 16 million people suffer hand injuries each year in the US, with over a quarter million being serious or disabling injuries. The most common types of injuries involve crushing, cuts, broken bones, and burns. Proper use of protective equipment and following safety guidelines can prevent many hand injuries, which are often caused by unguarded machinery, improper tool use, lack of gloves or guards, and hazardous chemicals.
- Construction workers face significant health risks from exposure to silica dust, which can lead to fatal lung diseases like silicosis. Over 500 workers in the UK are estimated to die from silica exposure each year.
- Exposure measurement studies show that workers performing tasks like drilling, demolition, and concrete grinding often experience respirable silica exposures above the UK limit of 0.1 mg/m3. Long-term or high-level exposures increase the risk of developing silicosis.
- Effective dust control measures during tasks that generate silica dust, such as using water sprays or extraction tools, are needed to reduce worker exposures and health risks from silica.
Shrm survey findings using competencies to achieve business unit success finalshrm
SHRM surveyed executives of business units other than HR (e.g., CEO, CFO, Vice President) to learn more about their views of what it takes for leaders to be successful across HR departments and different functional areas such as finance and accounting, sales and marketing, and IT. Specifically, this report focuses on the competencies needed now and in the future, including Business Acumen, Communication, Consultation, Critical Evaluation, Ethical Practice, Global and Cultural Effectiveness, Human Resource Expertise, Leadership and Navigation, and Relationship Management. The report also looks at which competencies are lacking in the labor pools of candidates for HR and other business units, and how to address those competency gaps.
Legalizing drugs would lead to significant health problems and addiction issues as crime and social problems would worsen. It would also send the wrong message, especially to young people, by normalizing drug use and increasing peer pressure. Legalization is opposed because it would exacerbate issues like aggression, violence, criminal behavior, and the existing widespread teen drug abuse problems in schools.
Consequences of Medical Marijuana legalizationSamJigo
The document discusses the consequences of legalizing medical marijuana. It outlines symptoms of marijuana use like rapid heart rate and memory loss. It also discusses potential health risks like cancer and addiction. However, it also reviews marijuana's medical properties in relieving pain, seizures, and other conditions. Studies from countries that have legalized marijuana, like Holland and Portugal, found crime and drug use did not significantly increase and in some cases decreased. The document aims to provide information to help decide whether to legalize medical marijuana.
This document discusses arguments for the legalization of marijuana. It notes that over 60 million people have been affected by marijuana law enforcement since 1985, while zero deaths have resulted from marijuana use alone. Mandatory minimum sentencing laws have severely punished minor marijuana offenses. The document also argues that marijuana has medical benefits and that hemp is a useful resource. It states that the war on drugs costs billions annually and fills prisons without reducing drug use or availability. The document compares the addictiveness and health effects of legal and illegal drugs, noting that marijuana is less addictive and has never directly caused a death. In conclusion, it questions why marijuana remains illegal given that it is less harmful than legal substances like alcohol and tobacco.
A fun take on a stigmatised topic. This project uses facts to put a case for drug legalisation in India taking examples of countries which are already reaping benefits from de criminalisation.
Over 16 million people suffer hand injuries each year, with over a quarter million being serious or disabling. The most common type of injury is crushing or compression, and men are 9 times more likely to be injured than women. Many injuries involve a lack of protective equipment or unsafe practices around machinery. Following guidelines like using guards and proper tools, wearing protective equipment, and disconnecting power before repairs can help reduce risks to hands on the job.
How to Become a Thought Leader in Your NicheLeslie Samuel
Are bloggers thought leaders? Here are some tips on how you can become one. Provide great value, put awesome content out there on a regular basis, and help others.
This document discusses SAM, a 501(c)(3) non-profit organization with a mission to educate citizens about the science of marijuana and promote health-focused policies to decrease marijuana use and its consequences. SAM operates through two branches - SAM Action promotes this mission through advocacy and policy work, while SAM conducts research into marijuana's negative effects and brings awareness. The document outlines SAM's scientific advisory board and collaborations with other public health organizations, and promotes an evidence-based approach to marijuana policy prioritizing public health.
This document provides a summary of a presentation on the risks of medical marijuana and marijuana legalization. It begins with disclosures from the presenters and outlines six learning objectives. It then discusses concerns that marijuana is addictive, especially for those who start using it early, and impacts adolescent brain development. The document notes the lack of evidence that marijuana is effective for the conditions it is claimed to treat. It also discusses the risks of increased diversion of marijuana to youth and greater social acceptance of marijuana use negatively impacting public health. The document concludes with messages on how to discuss these issues with the public.
This document provides information about an advocacy track presentation on advocating for change related to addiction issues. The presentation features Gary Mendell, founder and CEO of Shatterproof, and Kim Manlove from the Indiana Addictions Issues Coalition. They will discuss strategies for influencing legislation and how people in recovery can become advocates. The learning objectives focus on advocating for state laws on PDMP usage, explaining strategies to influence legislation, describing how people in recovery can advocate, and providing counsel as part of a treatment team. The presentation then provides details on Shatterproof's story, the overdose epidemic, solutions for different populations, and legislative accomplishments in various states related to expanding access to naloxone and mandating PDMP usage.
Cannabis as Medicine: Redefining the Paradigm of the Doctor-Patient Relations...Canna Holdings, LLC
Dr. D'Angelo will cover the need and best practices for maintaining a standard of care in a changing medical environment, and establish the responsibilities of the patient and provider during cannabis therapy treatments.
This document discusses the history of drug regulation laws in the United States. It begins by covering early federal laws like the 1906 Pure Food and Drug Act that required labeling of drug contents but did little to regulate safety. The 1938 Food, Drug, and Cosmetic Act and later amendments in 1951 and 1962 strengthened regulations by requiring pre-market approval of drugs as safe and effective. The Controlled Substances Act of 1970 established a drug scheduling system to regulate substances based on abuse and medical potential. The document also discusses issues around legalization debates, prevention strategies, drug testing policies, and criticisms of discriminatory enforcement practices.
This document provides an overview of the debate around whether marijuana should be legalized in the United States. It outlines some of the key arguments on both sides of the issue, including potential benefits such as reduced drug costs and trafficking versus potential harms such as increased addiction and traffic accidents. The document also provides background on marijuana and its current legal status in different states.
This document discusses the link between marijuana use and mental illness. It outlines several studies that have found regular marijuana use increases the risk of developing psychotic illnesses like schizophrenia, especially for those with a family history or who start using in adolescence. The document also discusses the experiences in Colorado since legalizing marijuana, including an increase in marijuana-related emergency room visits and traffic deaths involving marijuana. The authors argue for a "smart approach" to marijuana policy that decreases access and availability, especially to youth, through prevention programs and increased treatment options rather than an "all or nothing" legalization vs prohibition debate.
College Student Perceptions of Marijuana 2015SarahMartin33
This marketing research project was created to better understand college students perceptions on marijuana. In this paper we cover background research concerning legalization of marijuana and behavior. After identifying questions that were not answered during our research, we administered a survey via Qualtrics and received over 700 responses from college students in different colleges in the nation. We took their responses and analyzed our data over SPSS. We discovered that most of our hypotheses held true.
Cannabis/Marijuana Report Recommendations Would Delay Legalization To 2018 Or...paul young cpa, cga
This presentation looks at the issues facing cannabis/pot/marijuana legalisation in Canada. There are many issues driving legalisation including policing, UN rules, United States Policies, enforcement, side-effects, etc.
Criminal Law Compliance For Healthcare Professionals - Painkiller LawMeister Law Offices
Steve Meister, an attorney from Los Angeles, gives a detailed explanation of the Painkiller Law purpose which is to help healthcare providers and professionals to verify, achieve and maintain compliance with the criminal laws of prescribing controlled substances.
Kyle molina harm reduction midterm project unm crp 275 community change in a ...Dr. J
Currently our country is experiencing a national health crisis of opiate use and opiate related overdoses, with the corona virus causing these problems to only get worse. In 2019 the number of drug overdoses in the United States rose by 4.6% , for a total of 70,980, with 50,042 involving opioids (American Hospital Association, 2020)
It is estimated around 130 people die each day due to overdose and since 2010 a total of 400,000 deaths have occurred (DrugAbuse.Gov)
Following national trends New Mexico has seen an increase in reported overdoses since the early 2000s and in 2018 63.0% of drug overdose deaths involved opioids with a total of more than 338 fatalities.(DrugAbuse.Gov)
Transmission of bloodborne diseases such as HIV and Hepatitis C is also an issue among the population who use intravenously.
This document analyzes the policy of decriminalizing recreational marijuana in the United States. It outlines the goals of decriminalization, which include treating marijuana similarly to alcohol and tobacco to reduce the burden of anti-cannabis laws. It notes over 750,000 marijuana arrests in 2012, costing $7.5-10 billion annually. Advantages include generating $8.7 billion in annual tax revenue and freeing law enforcement resources. Disadvantages include potential health risks and easier youth access. Overall the document argues the benefits of legalization outweigh the costs.
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwardsOPUNITE
The document summarizes a presentation on collaboration, coordination, and data to address prescription drug abuse at the state level. It discusses Tennessee's Prescription for Success initiative, which brought together multiple state agencies under the Public Safety Subcabinet to develop a coordinated action plan. The plan focused on three key initiatives: reducing violent crime, addressing repeat offenders, and creating an environment for job growth. One outcome was a law requiring prescribers and dispensers to use the state's prescription drug monitoring program to curb doctor shopping and misuse. The initiative emphasizes cross-agency collaboration and using data to develop tailored community responses and mobilize resources to combat prescription drug abuse.
The document summarizes a Heroin Response Strategy presented by experts from various High Intensity Drug Trafficking Areas. The strategy involves 3 components: 1) Establishing a regional public health and public safety information sharing network through "Points of Light" teams in each state. 2) Implementing community education and prevention programs. 3) Creating a platform for regional public health and public safety partnerships through annual symposiums. The goal is to reduce drug overdoses through enhanced collaboration between law enforcement and health agencies.
Addiction Medicine: Closing the Gap between Science and PracticeCenter on Addiction
These slides accompany CASAColumbia's report, Addiction Medicine: Closing the Gap between Science and Practice, published in June 2012, which found that, despite the prevalence of addiction, the enormity of its consequences, the availability of effective solutions and the evidence that addiction is a disease, both screening and early intervention for risky substance use are rare, and only about 1 in 10 people with addiction involving alcohol or drugs other than nicotine receive any form of treatment.
Cannabis Program Webinar Series - Paul Armentano of Deputy Director of NORMLEilera Deathfire
This document summarizes the existing legal landscape around cannabis regulation in the United States, including at the state and federal level. It also discusses the positions of major presidential candidates on cannabis issues and analyzes the potential impact of the 2016 election outcomes. Additionally, it reviews the history of efforts to reschedule cannabis under federal law and considers what rescheduling may achieve.
This document summarizes a presentation on best practices for treating opioid addiction in the criminal justice population. It outlines the challenges of treatment in this population and identifies best practices for using medication-assisted treatment (MAT) and behavioral therapy. The presentation reviews key points from the ASAM National Practice Guideline, including that MAT is the standard of care for opioid use disorder and should be continued, initiated, or made available for inmates. Discontinuing treatment can be dangerous and contradicts evidence-based practices. The implications discussed are that the guideline supports higher quality care for inmates and a rehabilitative approach, while also helping to address the opioid epidemic.
The document discusses Canada's plans to legalize marijuana. It outlines the agenda, including definitions of marijuana, potential short-term and long-term health effects, the UN's stance on drug enforcement worldwide, and the costs associated with implementing legalization. The author estimates the potential market size in Canada could be $5-8.7 billion annually and outlines leading marijuana companies like Canopy Growth Corp. The document concludes that marijuana should be legalized but the government must fully fund associated health, legal and regulatory costs and work with other countries to change international drug laws.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Mercurius is named after the roman god mercurius, the god of trade and science. The planet mercurius is named after the same god. Mercurius is sometimes called hydrargyrum, means ‘watery silver’. Its shine and colour are very similar to silver, but mercury is a fluid at room temperatures. The name quick silver is a translation of hydrargyrum, where the word quick describes its tendency to scatter away in all directions.
The droplets have a tendency to conglomerate to one big mass, but on being shaken they fall apart into countless little droplets again. It is used to ignite explosives, like mercury fulminate, the explosive character is one of its general themes.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
62. Note: This presentation is not intended to provide legal advice of any kind. For legal advice, please contact a lawyer in the appropriate jurisdiction.
jeff@learnaboutsam.org
Jeff Zinsmeister
Editor's Notes
Marijuana use is strongly linked to poorer outcomes later in life.
The relationship between marijuana use and poor life outcomes appears to be dose dependent. Illustrated are the results of a 25-year longitudinal study of a New Zealand birth cohort showing associations between increasing levels of cannabis use at ages 14-21 and: higher levels of welfare dependence; higher unemployment; lower income at age 25; and lower levels of academic degree attainment by age 25.
These results are consistent with an earlier study in the US showing poorer outcomes for chronic marijuana users in terms of education attained, household income, and overall life satisfaction. (Gruber, AJ et al., Psychological Medicine, 33, pp. 1415-1422, 2003.)
Estimated annual cost to U.S. employers for alcohol: $185 billion (National Institute on Alcohol Abuse and Alcoholism, 2006): http://www.forbes.com/2006/08/22/health-drinking-problems_cx_mh_nightlife06_0822costs.html
$135 billion (CDC, 2013): http://www.cdc.gov/workplacehealthpromotion/evaluation/topics/substance-abuse.html
Forbes article also says that 60% of employer costs are not from dependent users, but from casual users.
Estimated annual cost to U.S. employers for tobacco: $278 billion (Gallup, 2013): http://www.forbes.com/2006/08/22/health-drinking-problems_cx_mh_nightlife06_0822costs.html